Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma player, with pharmaceutical revenues of…

Chantal Depondt, president of the Belgian Neurological Society (BNS), introduces the mission of the professional association and offers her insights…

Newly-appointed general manager of UCB France, Catherine Rives, discusses what drew her back to the company after time away, market access issues in…

Hande Demirdere, general manager of Pierre Fabre Pharma in Turkey, sheds light on the affiliate’s impressive 93 percent growth in 2017 while…

Terry O’Regan, VP and managing director at Biogen UK and Ireland, discusses the company’s longstanding commitment to the UK, market access issues,…

Lee Ferreira, newly-appointed general manager of Ferring Pharmaceuticals Canada, shares her excitement about the company’s transformative changes.…

Recipient of the 2018 Brain Prize for research for groundbreaking research on the generic and molecular basis of Alzheimer’s Disease, the UCL’s…

Red Leaf Medical, founded in 2009, is unique in its approach to the Canadian healthcare market, being the only company focused exclusively on urology…

Alessandro di Napoli, CEO of Swiss family-owned pharmaceutical group, TRB Chemedica, discusses the company’s focus on the rheumatology,…

In 2016, rumours of a weakening FDA followed a disappointing 16 new drugs approved for the full year. However, since the beginning of 2017 the FDA has…

Appointed in the midst of the Greek economic crisis, compounded by significant changes at the corporate Merck brand, Merck Greece’s MD, Konstantinos…

Boston Scientific is raising the bar for medical devices and services in the field of cardiology and other pathologies, including Rhythm Management,…